CDC Taps Palantir to Support COVID-19 Drug Supply in US

CDC Taps Palantir to Support COVID-19 Drug Supply in US
The logo of U.S. software company Palantir Technologies in Davos, Switzerland, on Jan. 22, 2020. Arnd Wiegmann/Reuters
Reuters
Updated:

The Centers for Disease Control and Prevention (CDC) has awarded Palantir Technologies Inc. a $5.3 million contract to manage distribution of COVID-19 drugs in the United States, the software maker said on Tuesday.

The contract for supporting distribution of therapeutics is for a duration of six months, Palantir said.